再鼎醫藥
0968820.2403.71% ( -0.780 )
延遲 已收盤: 11月13日 16:08:17股東
全部股東
股東類型
- 機構投資者58.89%
- 公眾及其他27.63%
- 對沖基金5.85%
- 創投/私募5.46%
- 個人與內幕人士2.17%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
RTW Investments, LP | 5.85% | 657.40 萬 | 0.01% | +0 | 30/06/2026 |
TCG Crossover Management, LLC | 5.46% | 613.76 萬 | -- | +613.76 萬 | 30/06/2026 |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 4.35% | 488.84 萬 | <0.01% | +0 | 31/12/2025 |
RA Capital Management, L.P. | 4.20% | 472.35 萬 | 0.92% | -102.00 萬 | 13/08/2026 |
Vanguard Capital Management, LLC | 3.70% | 416.24 萬 | 0.15% | -16.12 萬 | 30/09/2026 |
FMR LLC | 3.08% | 345.85 萬 | 2.03% | -227.23 萬 | 30/09/2026 |
ADAR1 Capital Management, LLC | 3.00% | 336.90 萬 | 1.73% | +194.37 萬 | 30/06/2026 |
China Universal Asset Management Company Ltd. | 2.90% | 326.32 萬 | <0.01% | +2,891.00 | 30/09/2026 |
The Goldman Sachs Group, Inc. | 2.79% | 314.05 萬 | 1.93% | -216.01 萬 | 22/10/2026 |
Wellington Management Group LLP | 2.75% | 309.28 萬 | <0.01% | +0 | 31/12/2025 |
Norges Bank Investment Management | 2.65% | 297.57 萬 | 0.79% | -89.23 萬 | 30/06/2026 |
JPMorgan Chase & Co. | 2.59% | 291.01 萬 | 1.64% | +184.29 萬 | 26/10/2026 |
BlackRock, Inc. | 2.33% | 262.49 萬 | 0.02% | +3.24 萬 | 30/10/2026 |
Woodline Partners LP | 1.96% | 220.73 萬 | 1.96% | +220.73 萬 | 30/06/2026 |
GF Fund Management Co., Ltd. | 1.71% | 192.52 萬 | <0.01% | +64.00 | 30/09/2026 |
Frazier Life Sciences Management, LP | 1.69% | 190.23 萬 | <0.01% | +0 | 30/06/2026 |
Baron Capital Group, Inc. | 1.45% | 163.59 萬 | 0.02% | -2.25 萬 | 30/06/2026 |
Two Sigma Investments, LP | 1.16% | 129.94 萬 | 0.88% | +98.97 萬 | 30/06/2026 |
Citadel Advisors LLC | 1.14% | 128.47 萬 | 0.36% | -40.39 萬 | 30/06/2026 |
Ying DuFounder, Chairperson & CEO | 1.09% | 122.14 萬 | 0.01% | +1.76 萬 |